Results 111 to 120 of about 29,611 (145)
Some of the next articles are maybe not open access.
Complications of SSRI Treatment
Journal of Child and Adolescent Psychopharmacology, 2001EVEN THOUGH THE SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) have a very favorable side-effect profile, problems can develop during treatment that can cause concern. Complications of treatment that are easiest to deal with are those that are expected, occur early in the course of treatment, are mostly physical in nature, and either go away on their ...
J, Walkup, M, Labellarte
openaire +2 more sources
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
Among drugs that act on serotonergic neurotransmission, selective serotonin (5-HT) reuptake inhibitors (SSRIs) are now the gold standard for the treatment of anxiety disorders. The precise mechanisms of the anxiolytic actions of SSRIs are unclear.
Takeshi, Inoue +2 more
openaire +2 more sources
Among drugs that act on serotonergic neurotransmission, selective serotonin (5-HT) reuptake inhibitors (SSRIs) are now the gold standard for the treatment of anxiety disorders. The precise mechanisms of the anxiolytic actions of SSRIs are unclear.
Takeshi, Inoue +2 more
openaire +2 more sources
Seminars in Perinatology, 2015
The Society of Maternal and Fetal Medicine recently had a conference on the use of medications during pregnancy, delivery, and breast-feeding. One of the most important topics covered during that 2-day conference was major depression (MDD) and the use of Serotonin Selective Reuptake Inhibitors (SSRIs).
Heather, Tran, Adelaide S, Robb
openaire +2 more sources
The Society of Maternal and Fetal Medicine recently had a conference on the use of medications during pregnancy, delivery, and breast-feeding. One of the most important topics covered during that 2-day conference was major depression (MDD) and the use of Serotonin Selective Reuptake Inhibitors (SSRIs).
Heather, Tran, Adelaide S, Robb
openaire +2 more sources
SSRI-to-SSRI Switching and Associated Dosing Characteristics
Journal of Managed Care Pharmacy, 1999OBJECTIVE: To evaluate antidepressant switching rates and associated dosing characteristics in patients undergoing therapy with one of the selective serotonin reuptake inhibitors (SSRls)-fluoxetine, paroxetine, or sertraline. DESIGN: A longitudinal, retrospective drug utilization analysis of administrative prescription claims for patients who initiated
openaire +1 more source
SSRI-Associated Sexual Dysfunction
American Journal of Psychiatry, 2006A 35-year-old woman was referred by her therapist for an evaluation of her sadness, irritability, fatigue, and poor concentration over a period of two and a half years, which did not improve significantly during the course of cognitive behavior therapy.
openaire +2 more sources
SSRIs versus Non-SSRIs in Post-traumatic Stress Disorder
Drugs, 2004Post-traumatic stress disorder (PTSD) is a highly prevalent (7.8% lifetime rate) anxiety disorder with impairment in daily functioning, frequent suicidal behaviour and high rates of co-morbidity. Fortunately, PTSD is responsive to pharmacotherapy and psychotherapy. The selective serotonin reuptake inhibitors (SSRIs) are the most studied medications for
Gregory M, Asnis +3 more
openaire +2 more sources
The SSRI discontinuation syndrome
Journal of Psychopharmacology, 1998A characteristic selective serotonin reuptake inhibitor (SSRI) discontinuation syndrome appears to exist. It is usually mild, commences within 1 week of stopping treatment, resolves spontaneously within 3 weeks, and consists of diverse physical and psychological symptoms, the commonest being dizziness, nausea, lethargy and headache. SSRI reinstatement
openaire +2 more sources